Concepedia

The cost-effectiveness of a bedaquiline-containing short-course regimen for the treatment of multidrug-resistant tuberculosis in South Africa

Abela Mpobela Agnarson, Abeda Williams, Chrispin Kambili, Gunnar Mattson, Laurent Metz

Expert Review of Anti-infective Therapy · 2020 · 20 citations · 37 references

DOI

Concepts

Abstract

: Replacing an injectable-containing SCR with a bedaquiline-containing SCR is cost-effective, offering a cost-saving alternative with improved patient outcomes for MDR-TB.

References

37

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Spencer L James, Degu Abate, Kalkidan Hassen Abate et al. · The Lancet · 2018 · 14K citations · Full text

, , +16

Cost–effectiveness thresholds: pros and cons

Melanie Bertram, Jeremy A. Lauer, Kees de Joncheere et al. · Bulletin of the World Health Organization · 2016 · 788 citations · Full text

, , +17

Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch et al. · New England Journal of Medicine · 2014 · 752 citations · Full text

, , +14

Rate of Reinfection Tuberculosis after Successful Treatment Is Higher than Rate of New Tuberculosis

Suzanne Verver, Robin M. Warren, Nulda Beyers et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 445 citations

, , +16

UK population norms for EQ-5D

Paul Kind, Geoffrey Hardman, Susan Macran · RePEc: Research Papers in Economics · 1999 · 442 citations

, , +16